EGLN2 Antibody | 25-225

EGLN2 Antibody | 25-225 | Gentaur UK, US & Europe Distribution

Host: Rabbit

Reactivity: Human, Mouse, Rat

Homology: N/A

Immunogen: Antibody produced in rabbits immunized with a synthetic peptide corresponding a region of human EGLN2.

Research Area: Transcription, Cancer

Tested Application: E, WB

Application: EGLN2 antibody can be used for detection of EGLN2 by ELISA at 1:62500. EGLN2 antibody can be used for detection of EGLN2 by western blot at 1 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50, 000 - 100, 000.

Specificiy: N/A

Positive Control 1: Cat. No. XBL-10407 - Fetal Heart Tissue Lysate

Positive Control 2: N/A

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: 16 kDa

Validation: N/A

Isoform: N/A

Purification: Antibody is purified by peptide affinity chromatography method.

Clonality: Polyclonal

Clone: N/A

Isotype: N/A

Conjugate: Unconjugated

Physical State: Liquid

Buffer: Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.

Concentration: batch dependent

Storage Condition: For short periods of storage (days) store at 4˚C. For longer periods of storage, store EGLN2 antibody at -20˚C. As with any antibody avoid repeat freeze-thaw cycles.

Alternate Name: EGLN2, EIT6, PHD1, HPH-1, HPH-3, HIFPH1, HIF-PH1

User Note: Optimal dilutions for each application to be determined by the researcher.

BACKGROUND: The hypoxia inducible factor (HIF) is a transcriptional complex which is involved in oxygen homeostasis. At normal oxygen levels, the alpha subunit of HIF is targeted for degration by prolyl hydroxylation. EGLN2 encodes an enzyme responsible for this posttranslational modification. Alternative splicing of EGLN2 results in three transcript variants encoding different isoforms.